Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1628 1692
This examiner grants 33% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18544236 | METHODS OF TREATING CANCER USING B-RAF INHIBITORS AND IMMUNE CHECKPOINT INHIBITORS | Final Rejection | Genentech, Inc. |
| 18387889 | USE OF HIGH MOLECULAR WEIGHT POLYETHYLENE GLYCOL COMPOSITIONS TO RESTORE THE EFFICACY OF PEGYLATED THERAPEUTIC COMPOSITIONS | Non-Final OA | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL |
| 18186698 | TARGETING SUCNR1 TO REDUCE NEUROINFLAMMATION | Non-Final OA | New York University |
| 18685717 | NOVEL PYRAZINYL-TRIAZOLE COMPOUNDS AS PESTICIDES | Non-Final OA | Bayer Aktiengesellschaft |
| 18428289 | COMPOSITIONS FOR TREATING SPINAL MUSCULAR ATROPHY | Non-Final OA | Hoffmann-La Roche Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy